Methodology breakdown computing — it will appear here on its own.
Immucell Corp. (ICCC) is currently considered halal (Sharia-compliant), per our secondary compliance provider (last assessed 2026-08-25). See the full ratio breakdown and business-activity screen below for the reasoning.
Computing the full ratio and business-activity breakdown for ICCC — this runs off the critical path so the page paints first. It will appear here on its own.
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally above. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 40.70 | NEUTRAL |
| Stochastic %K (14) | 30.59 | NEUTRAL |
| CCI (20) | -109.46 | BUY |
| Williams %R (14) | -69.41 | NEUTRAL |
| MACD (12,26,9) | 0.01 | BUY |
| ROC (10) | -1.70 | SELL |
| Momentum (10) | -0.17 | SELL |
| EMA (10) | 9.93 | SELL |
| SMA (10) | 9.91 | SELL |
| EMA (20) | 10.06 | SELL |
| SMA (20) | 9.93 | SELL |
| EMA (30) | 10.16 | SELL |
| SMA (30) | 10.28 | SELL |
| EMA (50) | 10.17 | SELL |
| SMA (50) | 10.56 | SELL |
| EMA (100) | 9.67 | BUY |
| SMA (100) | 9.94 | SELL |
| EMA (200) | 8.39 | BUY |
| SMA (200) | 8.12 | BUY |
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
Healthcare · Biotechnology
ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that improves the health and productivity of dairy and beef cattle in the United States and internationally. It operates through two segments, Scours and Mastitis. The company offers First Defense, an orally delivered scours preventive product for calves with claims against E. coli, coronavirus, and rotavirus; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. It also provides California Mastitis Test, a quick on-farm diagnostic that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, a bivalent gel tube formulation. In addition, the company developing Re-Tain Drug Product, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is based in Portland, Maine.
Background via Yahoo Finance — informational, not part of the verdict.
🟠 NOT YET
The main driver: lagging the market by 10.0%. More negatives than positives right now. The setup isn't ready — check back when the trend or RSI changes.
Scores: 0 bullish / 2 bearish
Weak — low conviction, small size or skip
| Timeframe | Bias | Bars |
|---|---|---|
| 📅 Daily | BEARISH | 62 |
| 🕐 1H | NEUTRAL | 35 |
| ⏱ 15-Min | BEARISH | 130 |
| ⏲ 5-Min | BEARISH | 234 |
Peer movement computing — it will appear here on its own.
NO DATA 0 buys · 0 sells
NEUTRAL report date 2026-09-01 · Asset managers net 934180 (-19048)
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.